| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.65B | 12.72B | 12.16B | 12.06B | 12.03B | 11.96B |
| Gross Profit | 11.65B | 10.19B | 11.62B | 11.96B | 11.93B | 11.86B |
| EBITDA | -823.00M | 1.29B | -921.00M | 1.72B | 1.76B | 1.43B |
| Net Income | -1.31B | 736.00M | -1.25B | 866.00M | 868.00M | 826.00M |
Balance Sheet | ||||||
| Total Assets | 815.00B | 794.05B | 805.10B | 828.95B | 839.88B | 842.25B |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 32.45B | 55.58B | 79.11B | 76.26B | 90.61B |
| Total Debt | 1.98B | 7.37B | 2.11B | 2.13B | 47.63B | 35.59B |
| Total Liabilities | 791.22B | 770.11B | 781.04B | 803.87B | 815.60B | 814.89B |
| Stockholders Equity | 23.62B | 23.78B | 23.91B | 24.94B | 24.13B | 27.22B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 12.91B | 6.03B | 0.00 | -7.67B | 12.79B |
| Operating Cash Flow | 0.00 | 13.07B | 7.31B | 0.00 | -7.43B | 13.18B |
| Investing Cash Flow | 0.00 | -14.30B | -3.38B | 1.49B | -6.45B | -14.22B |
| Financing Cash Flow | 0.00 | -22.71B | -20.80B | -140.00M | -140.00M | -1.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ¥14.29B | 9.59 | ― | 3.30% | 20.18% | 20.57% | |
68 Neutral | ¥12.87B | 7.27 | ― | 3.74% | 15.32% | 26.30% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
62 Neutral | ¥13.66B | 7.95 | ― | 3.58% | 18.86% | 59.05% | |
59 Neutral | ¥17.73B | 9.06 | ― | 3.37% | 6.15% | -0.87% | |
58 Neutral | ¥11.51B | 11.28 | ― | 2.68% | 24.95% | 10.64% | |
52 Neutral | ¥12.87B | 17.29 | ― | 1.89% | 17.42% | ― |